Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/6/2025

Steroid Use in Respiratory Conditions

Introduction to Steroid Use

  • The American College of Physicians recommends that systemic corticosteroids are not justified for acute bronchitis in healthy adults, as the clinical course is self-limited, resolving spontaneously after approximately 10 days 1
  • The American Thoracic Society suggests that purulent sputum does not indicate bacterial superinfection and does not justify steroid treatment in uncomplicated acute bronchitis 1

Asthma Management

  • The American College of Chest Physicians recommends initial therapy including inhaled corticosteroids combined with bronchodilators for asthma patients presenting with cough 2
  • For severe or refractory asthmatic cough, a short course of oral corticosteroids followed by inhaled corticosteroids is recommended by the National Asthma Education and Prevention Program 2
  • The Global Initiative for Asthma suggests that inhaled corticosteroids should be continued long-term for maintenance in asthma patients 2

COPD Management

  • The Global Initiative for Chronic Obstructive Lung Disease recommends systemic corticosteroids for acute exacerbations of COPD, with a standard regimen of prednisone 40 mg daily for 5-7 days 1, 4
  • The American College of Chest Physicians suggests that long-term oral corticosteroids should not be used for maintenance therapy in stable chronic bronchitis, but inhaled corticosteroids may be beneficial for patients with severe disease 4

Steroid Use Considerations

  • The American College of Physicians warns that corticosteroids can cause significant side effects, including immunosuppression, hyperglycemia, and osteoporosis, particularly with prolonged use 4
  • The European Respiratory Society notes that intranasal steroids are ineffective for common cold symptoms, including cough 5
  • The American Thoracic Society recommends that inhaled corticosteroids should not be routinely prescribed for chronic cough in patients with idiopathic pulmonary fibrosis or sarcoidosis 6, 7